CARE™ Breast Cancer Discussion Series

Integration and Experience with Novel Therapies in metastatic Breast Cancer

Part 1 in Series

Breast Cancer

Oncology

03 Nov 2021

Introduction

Welcome to the first issue in the CARE™ Breast Cancer Discussion series with CARE™
Oncology Faculty members, Dr. Sandeep Sehdev and Dr. Jan-Willem Henning.
This report provides a summary of the discussion had by Drs. Sehdev and Henning on
challenges and controversies in management of HER2 positive breast cancer, informed by
recent data and drug approvals.

In the next segment of the CARE™ Breast Cancer Discussion Series, Faculty will take a more in depth look and provide updates on the clinical trials discussed in this publication as presented at this year’s ESMO 2021 Congress. Stay tuned!